Heron Therapeutics (HRTX) Cash from Operations (2010 - 2026)
Heron Therapeutics' (HRTX) quarterly Cash from Operations came in at 1540000.0 in Q1 2026, up 82.64% YoY from 843197.53 in Q1 2025, and up 83.23% on a QoQ basis from 9184000.0 in Q4 2025.
Heron Therapeutics (HRTX) Cash from Operations (2010 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 17 years of Cash from Operations data on file, last reported at 1540000.0 in Q1 2026.
- Quarterly Cash from Operations rose 82.64% year-over-year to 1540000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20261000.0 (up 7.41% YoY) and the FY2025 annual result came in at 27591000.0, down 22.47% from the prior year.
- Cash from Operations rose to 1540000.0 in Q1 2026, from 9184000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 3371000.0 in Q3 2024 to a low of 43939000.0 in Q1 2022.
- A 5-year average of 15138882.35 and a median of 9516000.0 in 2024 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 136.73% in 2024, down 579.84% in 2024.
- Tracing HRTX's Cash from Operations over 5 years: stood at 37534000.0 in 2022, then soared by 106.54% to 2455000.0 in 2023, then slumped by 579.84% to 11780000.0 in 2024, then grew by 22.04% to 9184000.0 in 2025, then jumped by 83.23% to 1540000.0 in 2026.
- The last three Cash from Operations figures came in at 1540000.0 (Q1 2026), 9184000.0 (Q4 2025), and 1331000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn | -2.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.21 Mn |
| Jun 30, 2026 | -2.21 Mn |
| Mar 31, 2026 | -1.54 Mn |
| Mar 31, 2026 | -1.54 Mn |
| Dec 31, 2025 | -9.18 Mn |
| Dec 31, 2025 | -9.18 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | -10.87 Mn |
| Jun 30, 2025 | -10.87 Mn |
| Mar 31, 2025 | -8.87 Mn |
| Mar 31, 2025 | -8.87 Mn |
| Dec 31, 2024 | -11.78 Mn |
| Dec 31, 2024 | -11.78 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | -4.60 Mn |
| Jun 30, 2024 | -4.60 Mn |
| Mar 31, 2024 | -9.52 Mn |
| Mar 31, 2024 | -9.52 Mn |